Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03490344
Title Short Course Daratumumab in Patients With Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center

multiple myeloma


Daratumumab + Lenalidomide

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.